Qing'E Formula Therapy on Menopausal Symptoms (Healthy Volunteers Recruitment for Control Study)
NCT ID: NCT01920997
Last Updated: 2013-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No drug intervention
The objective of this study is to investigate the expression of NEI network and urine metabolomics of healthy women with normal menstrual cycles.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The score of Kupperman index is less than 15.
3. Not alcoholics or smokers (past or smoking).
4. Get subjects informed consent process should comply with GCP requirements.
Exclusion Criteria
2. Volunteers are participating in other clinical trials within 3 months.
3. Volunteers who donated blood or loosed blood heavily within 3 months.
4. Volunteers with previous history of mental illness, drug abuse or drug dependence.
5. Volunteers who took drugs within 14 days before the trail.
40 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wuxi People's Hospital
OTHER
Shanghai University of Traditional Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yang Jie, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QE-2458-3
Identifier Type: -
Identifier Source: org_study_id